Suppr超能文献

描述乳糜泻相关的燕麦蛋白:为开发适合乳糜泻患者的高质量燕麦品种奠定基础。

Characterization of celiac disease related oat proteins: bases for the development of high quality oat varieties suitable for celiac patients.

机构信息

Instituto de Agricultura Sostenible, CSIC, Córdoba, Spain.

INSERM U1218 "ACTION", Bordeaux University, Bordeaux Cedex, France.

出版信息

Sci Rep. 2017 Feb 17;7:42588. doi: 10.1038/srep42588.

Abstract

Some studies have suggested that the immunogenicity of oats depends on the cultivar. RP-HPLC has been proposed as a useful technique to select varieties of oats with reduced immunogenicity. The aim of this study was to identify both the avenin protein patterns associated with low gluten content and the available variability for the development of new non-toxic oat cultivars. The peaks of alcohol-soluble avenins of a collection of landraces and cultivars of oats have been characterized based on the RP-HPLC elution times. The immunotoxicity of oat varieties for patients with celiac disease (CD) has been tested using a competitive ELISA based on G12 monoclonal antibody. The oat lines show, on average, seven avenin peaks giving profiles with certain similarities. Based on this similarity, most of the accessions have been grouped into avenin patterns. The variability of RP-HPLC profiles of the collection is great, but not sufficient to uniquely identify the different varieties of the set. Overall, the immunogenicity of the collection is less than 20 ppm. However, there is a different distribution of toxicity ranges between the different peak patterns. We conclude that the RP-HPLC technique is useful to establish groups of varieties differing in degree of toxicity for CD patients.

摘要

一些研究表明,燕麦的免疫原性取决于品种。反相高效液相色谱法(RP-HPLC)已被提议作为一种有用的技术,用于选择免疫原性降低的燕麦品种。本研究的目的是鉴定与低麸质含量相关的醇溶蛋白图谱,并确定可用于开发新的无毒燕麦品种的可变性。基于 RP-HPLC 洗脱时间,对一组燕麦地方品种和栽培品种的醇溶蛋白峰进行了特征描述。使用基于 G12 单克隆抗体的竞争 ELISA 方法,测试了燕麦品种对乳糜泻(CD)患者的免疫毒性。燕麦品系平均显示出七个醇溶蛋白峰,呈现出一定的相似性图谱。基于这种相似性,大多数品系被分为醇溶蛋白图谱组。该集合的 RP-HPLC 图谱的可变性很大,但不足以唯一识别集合中的不同品种。总体而言,该集合的免疫原性小于 20ppm。然而,不同峰型之间的毒性范围分布存在差异。我们得出结论,RP-HPLC 技术可用于为 CD 患者建立具有不同毒性程度的品种组。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/104f/5314403/f1b54b4eff98/srep42588-f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验